Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial

Vladimir Lomivorotov, Dmitry Ponomarev, Vladimir Boboshko, Vladimir Shmyrev, Samandar Ismoilov, Sergey Efremov, Nikolay Kamenshchikov, Boris Akselrod, Vadim Pasyuga, Dmitry Urusov, Alexey Ovezov, Mikhail Evdokimov, Alexander Turchaninov, Alexander Bogachev-Prokofiev, Nazar Bukamal, Sarah Afifi, Alessandro Belletti, Rinaldo Bellomo, Giovanni Landoni

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Introduction: Weaning from cardiopulmonary bypass (CPB) is a critical step of any cardiac surgical procedure and often requires pharmacologic intervention. Calcium ions are pivotal elements for the excitation-contraction coupling process of cardiac myocytes. Thus, calcium administration might be helpful during weaning from CPB.

    Methods: We describe a multicenter, placebo-controlled, double blind randomized clinical trial to assess the effect of calcium chloride on the need for inotropic support among adult patients during weaning from CPB. The experimental group (409 patients) will receive 15 mg/kg of calcium chloride. The control group (409 patients) will receive an equivalent volume of 0.9% sodium chloride. Both drugs will be administered intravenously as a bolus at the beginning of weaning from CPB.

    Results: The primary outcome will be the need for inotropic support between termination of CPB and completion of surgery. Secondary outcomes will be: duration of inotropic support, vasoactive-inotropic score 30 min after transfer to intensive care unit and on postoperative day 1, plasma alpha-amylase on postoperative day 1, plasma Ca2+ concentration immediately before and 10-15 min after calcium chloride administration, non-fatal myocardial infarction, blood loss on postoperative day 1, need for transfusion of red blood cells, signs of myocardial ischemia on electrocardiogram after arrival to intensive care unit, all-cause mortality at 30 days or during hospital stay if this is longer than 30 days.

    Discussion: This trial is designed to assess whether intravenous calcium chloride administration could reduce the need for inotropic support after cardiopulmonary bypass weaning among adults undergoing cardiac surgery.

    Original languageEnglish
    Pages (from-to)100835
    JournalContemporary Clinical Trials Communications
    Volume23
    DOIs
    StatePublished - 2021

    Keywords

    • Cardiac surgery
    • Cardiopulmonary bypass
    • Calcium chloride
    • Hypocalcemia
    • Inotropic support

    Fingerprint

    Dive into the research topics of 'Calcium administration In patients undergoing CardiAc suRgery under cardiopulmonary bypasS (ICARUS trial): Rationale and design of a randomized controlled trial'. Together they form a unique fingerprint.

    Cite this